Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Accumulated Depreciation (2018 - 2019)

X4 Pharmaceuticals (XFOR) has disclosed Accumulated Depreciation for 2 consecutive years, with $305000.0 as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Accumulated Depreciation changed N/A year-over-year to $305000.0, compared with a TTM value of $305000.0 through Jun 2019, changed N/A, and an annual FY2018 reading of $176000.0, changed N/A over the prior year.
  • Accumulated Depreciation was $305000.0 for Q2 2019 at X4 Pharmaceuticals, up from $176000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $305000.0 in Q2 2019 and bottomed at $176000.0 in Q4 2018.